A step-change in medical imaging
Technology to product
Sonosine’s ground-breaking Electro Magnetic Acoustics (EMA) imaging technology, embedded in our Pulsar 1 medical imaging scanner, is set to dramatically improve medical diagnostics. It uses radio signals as well as ultrasound, revealing the tissue types in areas of concern in a way that ultrasound alone cannot.
System demonstrators have shown that Sonosine’s patented Electro-Magnetic Acoustic (EMA) imaging technology is easy to integrate into existing commercial scanners.
Find out more about the way our technology works in this video to the right.
Into the hands of clinicians
From the science base to the World
At Sonosine, we are drawing on years of deep technical knowledge and scientific research. Founded as a spin out company in 2015, the company now known as Sonosine, can trace its roots back to the University of Oxford, where our technology was developed.
Nine years before Sonosine was established, a team of scientists at the University of Oxford , led by our founder, Professor David Edwards, then Professor of Engineering Science, developed new technology that they knew was set to send ripples through the medical imaging and diagnostics world. Professor Edwards is still closely involved with Sonosine, working as our Chief Technology Officer.
A 21st century solution
In 2006, the team at the Univeristy of Oxford developed a technique called Electro Magnetic Acoustic (EMA) imaging. EMA uses a combination of radio signals and ultrasound to effectively shake very small volumes of tissue in the area of interest scanned. A radio frequency signal illuminates this area and the detection of its echo return enables differentiation between tissue types within the scanned area. Ultrasound alone, cannot do this. This technique enables clinicians to see problem areas of the body and can identify the accumulation of fluid, calcification, capillarisation, and other tissue differences.